DBV Technologies | DBVT - 借入資本





借入資本 変化する 日付
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
DBV Technologies USD 0 0 2025-03
Galectin Therapeutics USD 93.42M 9.08M 2024-06
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Incyte USD 28.42M 994K 2026-06
Insmed USD 543.51M 1.3M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06